文献速递牙周病

丁基甲苯胺蓝介导光动力治疗对2型糖尿病患者牙周愈合的影响

Effect of butyl toluidine blue-mediated photodynamic therapy on periodontal healing in Type 2 diabetic patients. A randomized clinical trial.
PubMed 文献 · J Dent · 2025-08-25

这项随机临床研究纳入42例伴残留牙周袋(PPD≥4 mm且探诊出血)的2型糖尿病患者,比较单纯龈下刮治与刮治联合丁基甲苯胺蓝介导光动力治疗的疗效。30例完成随访,结果显示联合组在90天和180天时牙周袋闭合比例更高、残留深袋更少,但两组免疫标志物未见显著差异。

要点

  • 刮治联合BuTB介导aPDT可提高2型糖尿病患者残留牙周袋的闭合率
  • 联合组在90天和180天时PPD≥4 mm的比例更低,CAL获得更优
  • 两组龈沟液免疫标志物在90天时无显著差异

核心结论

  • 在龈下刮治基础上加用丁基甲苯胺蓝介导的光动力治疗,可使2型糖尿病患者的残留牙周袋获得更有利的临床反应。

研究设计与样本

  • 随机临床研究,纳入42例伴残留牙周袋(PPD≥4 mm且探诊出血)的2型糖尿病患者,30例完成随访。

主要发现

  • 两组牙周临床参数随时间均有改善,联合组在90天和180天时牙周袋闭合(PPD≤3 mm)比例显著更高、PPD≥4 mm比例更低。
  • 联合组在90天和180天时PPD≥4 mm的减少幅度更大,90天时CAL获得显著改善(p < 0.05)。
  • 两组在90天时龈沟液免疫标志物未见显著差异。

关键数值与推荐

  • 残留牙周袋定义为PPD≥4 mm且探诊出血。
  • 光动力治疗参数为袋内冲洗丁基甲苯胺蓝后,以660 nm二极管激光100 mW照射50 s。

临床怎么用

  • 对血糖控制不佳的2型糖尿病患者,可在龈下刮治基础上辅以BuTB介导aPDT处理残留牙周袋,或有助于减少未来手术干预与再治疗需求。

局限性

  • 42例入组中仅30例完成随访,存在失访。
  • 免疫标志物仅报告90天时点,观察期有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to evaluate the photodynamic effect of butyl toluidine blue (BuTB) as an adjuvant therapy for the treatment of residual periodontal pockets in patients with type 2 diabetes mellitus (DM2). METHODS: This randomized clinical study comprised 42 DM2 patients with residual periodontal pockets, defined as probing pocket depth (PPD) ≥ 4 mm and bleeding on probing (BOP). Subjects were assigned to one of the following groups: Subgingival instrumentation (SI): SI performed in a single session; and SI + antimicrobial photodynamic therapy (aPDT): SI in a single session, followed by pocket irrigation with BuTB and irradiation with a 660 nm diode laser at 100 mW for 50 s. Periodontal clinical parameters, glycated hemoglobin levels, and immunological markers in crevicular fluid were assessed at baseline, and after 90 and 180 days. RESULTS: A total of 30 patients completed the study follow-up. Clinically, both groups showed improvements in periodontal parameters over time. The SI + aPDT group exhibited a significantly higher percentage of closed pockets (PPD ≤ 3 mm) and a lower percentage of moderate or deep pockets (PPD ≥ 4 mm) at 90 and 180 days compared to the SI group. BOP was significantly lower in the SI + aPDT group at baseline and 90 days. A reduction in PPD ≥ 4 mm and a gain in clinical attachment level (CAL) were observed at both 90 and 180 days in both groups compared to baseline. In the intergroup analysis, the SI + aPDT group showed a greater reduction in PPD ≥ 4 mm at 90 and 180 days, as well as a significantly improved CAL gain at 90 days compared to the SI group (p < 0.05). No significant differences were observed between groups in immunological biomarkers (90 days period). CONCLUSION: Both treatment approaches improved periodontal parameters over time. However, the adjunctive use of BuTB-mediated aPDT with SI led to a significantly higher percentage of closed pockets (PPD ≤ 3 mm) and a lower proportion of persistent residual pockets (PPD ≥ 4 mm), indicating a more favorable clinical response in the test group. CLINICAL SIGNIFICANCE: Local adjuvant therapy, such as aPDT, in the treatment of residual periodontal pockets may reduce the need for future surgical interventions and retreatment in patients with uncontrolled DM2.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Theodoro LH, Rodrigues JVS, Cláudio MM, et al. Effect of butyl toluidine blue-mediated photodynamic therapy on periodontal healing in Type 2 diabetic patients. A randomized clinical trial. J Dent. 2025. PMID: 40865714. doi:10.1016/j.jdent.2025.106060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。